DK0451547T3 - 1,4,8-triazacyclotridecanderivater med prolylendopeptidase inhiberende aktivitet - Google Patents

1,4,8-triazacyclotridecanderivater med prolylendopeptidase inhiberende aktivitet

Info

Publication number
DK0451547T3
DK0451547T3 DK91104163.0T DK91104163T DK0451547T3 DK 0451547 T3 DK0451547 T3 DK 0451547T3 DK 91104163 T DK91104163 T DK 91104163T DK 0451547 T3 DK0451547 T3 DK 0451547T3
Authority
DK
Denmark
Prior art keywords
triazacyclotridecane
derivatives
inhibitory activity
prolyl endopeptidase
endopeptidase inhibitory
Prior art date
Application number
DK91104163.0T
Other languages
English (en)
Inventor
Toda Soichiro
Oki Toshikazu
Hamagishi Yasutaro
Tomita Koji
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of DK0451547T3 publication Critical patent/DK0451547T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10Nitrogen as only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D255/00Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00
    • C07D255/02Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00 not condensed with other rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/886Streptomyces

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Neurology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Neurosurgery (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK91104163.0T 1990-03-22 1991-03-18 1,4,8-triazacyclotridecanderivater med prolylendopeptidase inhiberende aktivitet DK0451547T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/497,292 US4999349A (en) 1990-03-22 1990-03-22 BU-4164E - A and B, prolyl endopeptidase inhibitors

Publications (1)

Publication Number Publication Date
DK0451547T3 true DK0451547T3 (da) 1993-12-29

Family

ID=23976256

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91104163.0T DK0451547T3 (da) 1990-03-22 1991-03-18 1,4,8-triazacyclotridecanderivater med prolylendopeptidase inhiberende aktivitet

Country Status (7)

Country Link
US (1) US4999349A (da)
EP (1) EP0451547B1 (da)
JP (1) JPH06339390A (da)
AT (1) ATE99298T1 (da)
CA (1) CA2038509A1 (da)
DE (1) DE69100865D1 (da)
DK (1) DK0451547T3 (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5073549A (en) * 1990-03-22 1991-12-17 Bristol-Myers Squibb Company BU-4164E - A and B, prolyl endopeptidase inhibitors and their methods of use
GB9024208D0 (en) * 1990-11-07 1990-12-19 Salutar Inc Compounds
DE69222142T2 (de) * 1991-06-20 1998-04-09 Snow Brand Milk Products Co., Ltd., Sapporo, Hokkaido Neuartige prolyl-endopeptidase-inhibitoren sna-115 und sna-115t, ihre herstellung, und hierbei verwendete stämme
AU7814301A (en) * 2000-08-02 2002-02-13 Slil Biomedical Corp Cyclic polyamine compounds for cancer therapy
US20030072715A1 (en) * 2000-08-02 2003-04-17 Benjamin Frydman Cyclic polyamine compounds for cancer therapy
JP4806628B2 (ja) 2003-05-05 2011-11-02 プロビオドルグ エージー グルタミニルシクラーゼ阻害剤
EP2338490A3 (en) 2003-11-03 2012-06-06 Probiodrug AG Combinations useful for the treatment of neuronal disorders
US7304086B2 (en) 2004-02-05 2007-12-04 Probiodrug Ag Inhibitors of glutaminyl cyclase
EP2089383B1 (en) 2006-11-09 2015-09-16 Probiodrug AG 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases
US9126987B2 (en) 2006-11-30 2015-09-08 Probiodrug Ag Inhibitors of glutaminyl cyclase
AU2008220785B2 (en) 2007-03-01 2013-02-21 Vivoryon Therapeutics N.V. New use of glutaminyl cyclase inhibitors
JP5667440B2 (ja) 2007-04-18 2015-02-12 プロビオドルグ エージー グルタミニルシクラーゼ阻害剤としてのチオ尿素誘導体
US8524654B2 (en) * 2007-05-21 2013-09-03 The Uab Research Foundation Prolyl endopeptidase inhibitors for reducing or preventing neutrophilic inflammation
JP5934645B2 (ja) 2009-09-11 2016-06-15 プロビオドルグ エージー グルタミニルシクラーゼ阻害剤としてのヘテロ環式誘導体
WO2011107530A2 (en) 2010-03-03 2011-09-09 Probiodrug Ag Novel inhibitors
JP5688745B2 (ja) 2010-03-10 2015-03-25 プロビオドルグ エージー グルタミニルシクラーゼ(qc、ec2.3.2.5)の複素環阻害剤
WO2011131748A2 (en) 2010-04-21 2011-10-27 Probiodrug Ag Novel inhibitors
EP2686313B1 (en) 2011-03-16 2016-02-03 Probiodrug AG Benzimidazole derivatives as inhibitors of glutaminyl cyclase
ES2812698T3 (es) 2017-09-29 2021-03-18 Probiodrug Ag Inhibidores de glutaminil ciclasa

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6137764A (ja) * 1984-07-31 1986-02-22 Suntory Ltd 抗プロリルエンドペプチダ−ゼ活性を有する新規生理活性化合物
EP0201743B1 (en) * 1985-04-16 1992-04-01 Suntory Limited Dipeptide derivatives of fatty acids, process for preparing them, pharmaceutical composition and use
JPH0623190B2 (ja) * 1985-04-16 1994-03-30 サントリー株式会社 インヒビタ−活性を有するn−アシルピロリジン誘導体及びその製法並びに用途
US4898940A (en) * 1985-08-30 1990-02-06 Bristol-Myers Company Peptide antibiotics
JPH0764834B2 (ja) * 1985-11-29 1995-07-12 サントリー株式会社 プロリルエンドペプチダーゼ阻害活性を有する新規ピロリジンアミド誘導体およびその製法並びに用途
CA1320734C (en) * 1986-02-04 1993-07-27 Suntory Limited Pyrrolidineamide derivative of acylamino acid and pharmaceutical composition containing the same
JPH08806B2 (ja) * 1986-11-18 1996-01-10 サントリー株式会社 プロリルエンドペプチダ−ゼ阻害作用を有する新規ピロリジンアミド誘導体
ES2103287T3 (es) * 1987-02-23 1997-09-16 Ono Pharmaceutical Co Nuevos derivados de tiazolidina.
US4857524A (en) * 1987-08-08 1989-08-15 Kissei Pharmaceutical Co., Ltd. Thiazolidine compounds and therapeutic method

Also Published As

Publication number Publication date
EP0451547B1 (en) 1993-12-29
CA2038509A1 (en) 1991-09-23
DE69100865D1 (de) 1994-02-10
ATE99298T1 (de) 1994-01-15
US4999349A (en) 1991-03-12
JPH06339390A (ja) 1994-12-13
EP0451547A1 (en) 1991-10-16

Similar Documents

Publication Publication Date Title
DK0451547T3 (da) 1,4,8-triazacyclotridecanderivater med prolylendopeptidase inhiberende aktivitet
DK0706393T3 (da) Immun-undertrykkende og antiallergiske forbindelser, f.eks. N-(3-oxohexanoyl)homoserin-lacton
DE59510421D1 (de) Substituierte Pyridylpyrazole
FI911096A7 (fi) N-(4-piperidyl) dihydrobenzofuran)karboxamid- eller n-(4-piperidyl)(dihydro-2h- benzopyran) karboxamidderivat.
ATE338744T1 (de) Hydrazonderivate
DK0876359T3 (da) (-)-cis-6(S)-phenyl-5(R)- [4-(2-pyrrolidin-1-ylethoxy)phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol-D-tartrat
NO885337D0 (no) D-cykloserin og dets promedikamenter for bedring av hukommelse.
DE69211182D1 (de) Pyranylcyanoguanidinderivate
FI911980L (fi) N-(3-fluor-2-fosfonylmetoxipropyl) -derivat av heterocykliska purin- och pyrimidinbaser, deras framstaellning och anvaendning.
ES2090099T3 (es) Derivados de piranil-cianoguanidina.
DE68918681D1 (de) Glycosidasehemmer.
PT843679E (pt) Derivados da1-(piperidinil 1,2-disubstituido)-(4-imidazole fundido)-piperidina
SE8902076D0 (sv) Derivatives of quinoline-3-carboxanilide
NO934722L (no) Amidderivater av antibiotika A 40926
DE69218552D1 (de) MOS-Operationsverstärkerschaltungsanordnung
NO930520L (no) Bifenyl-substituerte kinolinderivater
LU91235I2 (fr) Palifermin et ses dérivés pharmaceutiquement acceptables (KEPIVANCE)
FI970448A7 (fi) N-substituoituja 3-atsobisyklo(3.2.0)heptaanijohdannaisia,jotka ovat k äyttökelpoisia neuroleptisina aineina
MY105128A (en) Bu-3608 derivatives.
ATE90105T1 (de) Glycosid-antibiotika bu-3608d und bu-3608e.
FI922954A0 (fi) Nya glykopeptider, foerfarande foer deras framstaellning och deras anvaendning.
FI883759A0 (fi) C.12-modifierade etromycin a-derivat.
AU7879487A (en) Proteine protease inhibitors from streptomyces
FI944678A7 (fi) 3,4-dihydro-2H-1-bentsopyraanien hydratsidijohdannaisia
DE58903780D1 (de) N-substituierte 3,4,5,6-tetrahydrophthalimid-derivate.